Cargando…
Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms
The delineation of the molecular pathology underlying amyotrophic lateral sclerosis (ALS) is being hampered by the lack of suitable biomarkers. We have previously reported that bromocriptine upregulates the endogenous antioxidative factor, neuronal apoptosis inhibitory protein (NAIP), sustains motor...
Autores principales: | Kano, Osamu, Tanaka, Kazunori, Kanno, Takuya, Iwasaki, Yasuo, Ikeda, Joh-E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758777/ https://www.ncbi.nlm.nih.gov/pubmed/29311650 http://dx.doi.org/10.1038/s41598-017-18627-w |
Ejemplares similares
-
Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset
por: Kano, Osamu, et al.
Publicado: (2013) -
Investigation of non-motor symptoms in patients with amyotrophic lateral sclerosis
por: Hirayama, Takehisa, et al.
Publicado: (2022) -
Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients
por: Nagata, Eiichiro, et al.
Publicado: (2016) -
Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients
por: Nagata, Eiichiro, et al.
Publicado: (2016) -
Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder
por: Zucchi, Elisabetta, et al.
Publicado: (2019)